HAGH and breast carcinoma: In this paper, considering the multiple aspects of Glo2, we wished to establish its possible presence in the nucleus of breast cancer cells (MCF7s), as compared to normal fibroblast-derived cells (HDFs), to assess its possible involvement in cancer cell proliferation, and we also aimed to evaluate the effect of Glo2 inhibition alone or in combination with doxorubicin.